Incidence of hyperkalemia RAASi and SGLT-2i treatment in individuals with diabetic kidney disease: a systematic review and network meta-analysis

Incidence of hyperkalemia RAASi and SGLT-2i treatment in individuals with diabetic kidney disease: a systematic review and network meta-analysis

BackgroundThis study aims to evaluate the incidence of hyperkalemia and serum potassium levels associated with the use of sodium-glucose cotransporter-2 inhibitors (SGLT-2i), renin‐angiotensin‐aldosterone system inhibitors (RAASi) and concurrent use of these medications in individuals with diabetic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yahui Yuan, Chun Chen, Yuping Lin, Yehao Luo, Zhaojun Yang, Jingyi Guo, Qiaoyun Liu, Lu Sun, Guanjie Fan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	diabetic kidney disease renin-angiotensin-aldosterone system inhibitors hyperkalemia SGLT-2i network meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1462965/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immune Optimization as a Preventive and Therapeutic Adjunct for the Management of Renin–Angiotensin–Aldosterone System Dysfunction Diseases: A Review
by: Michael T. Okafor, et al.
Published: (2024-07-01)

Renin–angiotensin–aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory study
by: Katharina Krenn, et al.
Published: (2025-01-01)

Case report: Persistent syndrome of inappropriate antidiuresis after traumatic brain injury: spontaneous resolution and impact on RAAS and bone metabolism over five years
by: Yaoxia Liu, et al.
Published: (2025-01-01)

Detection of Deaths Caused by Hyperkalemia
by: Małgorzata Żulicka, et al.
Published: (2025-01-01)

Effects of salbutamol on serum potassium level and electrocardiography in experimental hyperkalemia in rabbits
by: Ramazan Bal, et al.

Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan
by: Simone Mazzetti, et al.
Published: (2020-06-01)

Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure
by: Masatake Kobayashi, et al.
Published: (2020-06-01)

Research Progress of SGLT2 Inhibitors in Cancer Treatment
by: Miao X, et al.
Published: (2025-01-01)

Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing’s syndrome
by: Peter Wolf, et al.
Published: (2025-01-01)

Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis
by: Chien‐Wei Huang, et al.
Published: (2025-02-01)

Metabolomic characteristics of cord blood from neonates with hyperkalemia after antenatal exposure to ritodrine and magnesium sulfate
by: Masanori Inoue, et al.
Published: (2025-01-01)

Genetics and pathophysiology of low-renin arterial hypertension
by: A. L. Markel
Published: (2019-01-01)

Hypertensive load predicts recovery of renal function for patients undergoing revascularisation for renal artery stenosis
by: Ben Edgar, et al.
Published: (2025-01-01)

Redefining outcomes of ventricular arrhythmia for SGLT2 inhibitor medication in heart failure patients: a meta-analysis of randomized controlled trials
by: Miao Lin, et al.
Published: (2025-02-01)

The protective role of SGLT2 inhibitors on aortic aneurysm mediated by oxidative stress and inflammation in type 2 diabetes mellitus
by: Rujie Zheng, et al.
Published: (2025-02-01)

First evidence of immunomodulation of the renin-angiotensin system through substance P/neurokinin 1 receptor: a case and control study in hypertension and cardiac patients
by: Ibrahim M. Alanazi, et al.
Published: (2025-02-01)

Antioxidant and Renin-Angiotensin System Inhibitory Properties of Cashew Nut and Fluted-Pumpkin Protein Hydrolysates
by: Sunday A. Malomo, et al.
Published: (2020-06-01)

Exploring the Mechanism of Canmei Formula in Preventing and Treating Recurrence of Colorectal Adenoma Based on Data Mining and Algorithm Prediction
by: Xiaoling Fu, et al.
Published: (2025-02-01)

Differential Effects of Alcoholic and Non-Alcoholic Beer Intake on Renin–Angiotensin System Modulation in Spontaneous Hypertensive Rats
by: María Dolores Mayas, et al.
Published: (2025-01-01)

Angiotensin IV Receptors in the Rat Prefrontal Cortex: Neuronal Expression and NMDA Inhibition
by: Zsolt Tamás Papp, et al.
Published: (2024-12-01)

The SGLT-2 Inhibitors and their Role in the Treatment of Heart Failure - A Review of Literature
by: Silvia Ciraolo, et al.
Published: (2025-02-01)

Cross-sectional association between plasma aldosterone concentration and cognitive performance by mini-mental state examination in community dwellers
by: Aketilieke Nusufujiang, et al.
Published: (2025-02-01)

Effect of SY009, a novel SGLT1 inhibitor, on the plasma metabolome and bile acids in patients with type 2 diabetes mellitus
by: Haoyi Yang, et al.
Published: (2025-01-01)

Decreased nitric oxide production is a novel therapeutic target for salt-induced nocturnal polyuria in aging
by: Takahiro Imanaka, et al.
Published: (2025-01-01)

Pitavastatin-attenuated cardiac dysfunction in mice with dilated cardiomyopathy via regulation of myocardial calcium handling proteins
by: Hu Wei, et al.
Published: (2014-03-01)

The influence of the pharmacodynamic properties of drugs on indications for their use: Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors)
by: Denda Nikola I., et al.
Published: (2024-01-01)

Exacerbation of diabetes due to F. Nucleatum LPS-induced SGLT2 overexpression in the renal proximal tubular epithelial cells
by: Aiko Seki, et al.
Published: (2025-01-01)

Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration
by: Zhijie Liu, et al.
Published: (2022-06-01)

Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes
by: Bethany Murphy, et al.
Published: (2025-01-01)

Renin-angiotensin-aldosterone system in ISIAH rats with stressinduced arterial hypertension
by: A. D. Dubinina, et al.
Published: (2017-02-01)

Refining Surface Copper Species on Cu/SiO<sub>2</sub> Catalysts to Boost Furfural Hydrogenation to Furfuryl Alcohol
by: Jieqiong Wang, et al.
Published: (2025-01-01)

Effectiveness of advanced cardiovascular life support in hyperkalemic cardiac arrest: A randomized experimental study in pigs
by: Najmiddin Mamadjonov, et al.
Published: (2025-01-01)

The Use of SGLT-2 Inhibitors and GLP-1RA in Frail Older People with Diabetes: A Personalised Approach Is Required
by: Alan J. Sinclair, et al.
Published: (2025-01-01)

Pathology and gene mutations of aldosterone-producing lesions
by: Koshiro Nishimoto, et al.
Published: (2023-12-01)

Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
by: Gilda M. Portalatin, et al.
Published: (2025-01-01)

Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan
by: Ken-ichiro Honma, et al.
Published: (2024-09-01)

Experimental Study on a Low-Rise Shear Wall with the Built-In Shear Steel Plate
by: Xingyu Song, et al.
Published: (2022-01-01)

20-HETE mediates Ang II-induced cardiac hypertrophy via ROS and Ca2+ signaling in H9c2 cells
by: Jingyi Han, et al.
Published: (2025-01-01)

Hypoglycaemia and monitoring practices following insulin-dextrose therapy for hyperkalaemia
by: Samuel Ford, et al.
Published: (2025-03-01)

Case report: Clinical characteristics and Genetical analysis of HSD11B2 in three Chinese children with apparent mineralocorticoid excess: a case series
by: Yuan Ding, et al.
Published: (2025-01-01)